Stock ScreenerStock IdeasStrong Financial HealthStrong Financial HealthA company's financial health is a key determinant of its ability to create shareholder value. Financials Rating puts significant emphasis on balance sheet strength and key financial stability indicators.
Stock ScreenerStock IdeasStrong Financial Health
Zen Rating: A + 1 more
Financials Rating: A + 1 more
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EVR | EVERCORE INC | $10.58B | $267.19 | $378.71 | 41.74% | 25.57% | Buy | Hold | 7 | 2 | 13.43% | 22.92% | N/A | N/A |
| EVER | EVERQUOTE INC | $584.40M | $16.22 | $27.00 | 66.46% | 74.68% | Strong Buy | Strong Buy | 5 | 3 | 12.29% | 0.08% | N/A | N/A |
| TPR | TAPESTRY INC | $28.89B | $142.67 | $148.15 | 3.84% | 8.43% | Strong Buy | Strong Buy | 13 | 10 | 4.87% | 43.84% | 306.07% | 25.83% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $2.10B | $8.38 | $21.86 | 160.82% | 172.08% | Buy | Buy | 7 | 5 | 0.86% | -23.25% | -350.50% | 81.23% |
| DDS | DILLARD's INC | $8.96B | $573.77 | $519.67 | -9.43% | -4.23% | Strong Sell | Sell | 3 | 2 | -1.01% | -2.36% | N/A | N/A |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.